The main activities financed from the allocated budget are [24,32,40]: information, education, communication and continuous staff training; SMBG of insulin-treated patients; access to insulin pumps and anti-diabetic care (oral antidiabetics and insulins); control of DM patients by periodic check-ups of HbA1c. The gene discussed is INS; the disease is diabetes mellitus.